Danish government makes vaccine production a priority in new life science strategy

Recent concerns on whether Denmark is properly protected in terms of access to vaccines have been implemented in the new national Danish life science strategy which was presented early Friday. The strategy mentions partnerships with the life science industry to strengthen vaccine access.

Photo: Christophe Ena/AFP / POOL

Following the outbreak of Covid-19, Denmark's capacity for producing vaccines has been a frequent case of debate. Now, this challenge is being addressed in the new life science strategy which the Danish government presented on Friday morning.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs